Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
If you have a proven intervention model to reduce liver disease and cancer burden in underserved populations, NIH will fund your multi-year research and clinical trial.
Report stale or inaccurate summary
What this is
This R01 grant from NIH targets researchers developing interventions—at individual, organizational, community, or policy levels—to address health disparities in liver disease and cancer outcomes. The initiative welcomes diverse applicants from nonprofits to for-profit organizations and academic institutions. Clinical trials are optional but supported. With a 4-year funding window and broad eligibility, this is suited for established research teams with evidence-based intervention models and demonstrated capacity to serve health-disparity populations.
Who can apply
Broad eligibility including nonprofits (with or without 501(c)(3) status), for-profits, small businesses, state/county/tribal governments, and public/private universities. Solo founders and pre-revenue startups are unlikely fit; established research programs or organizations with clinical/community infrastructure are strongly preferred.
Eligible applicant types
- City or township governments
- Independent school districts
- Public housing authorities/Indian housing authorities
- Public and State controlled institutions of higher education
- County governments
- Private institutions of higher education
- Native American tribal governments (Federally recognized)
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Special district governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- State governments
- Native American tribal organizations (other than Federally recognized tribal governments)
- Small businesses
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Full description — from the agency
This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (U.S.). This NOFO is being reissued in accordance with the simplified review criteria in effect for application due dates after January 25, 2025.
Topics: liver disease disparities · health equity intervention · liver cancer prevention · clinical research · health disparities · r01 grant · nih funding
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.